Chaitan Phd Khosla - Net Worth and Insider Trading
Chaitan Phd Khosla Net Worth
The estimated net worth of Chaitan Phd Khosla is at least $0 dollars as of 2024-11-13. Chaitan Phd Khosla is the Director of Protagonist Therapeutics Inc and owns about 0 shares of Protagonist Therapeutics Inc (PTGX) stock worth over $0. Details can be seen in Chaitan Phd Khosla's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chaitan Phd Khosla has not made any transactions after 2020-08-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chaitan Phd Khosla
Chaitan Phd Khosla Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chaitan Phd Khosla owns 1 companies in total, including Protagonist Therapeutics Inc (PTGX) .
Click here to see the complete history of Chaitan Phd Khosla’s form 4 insider trades.
Insider Ownership Summary of Chaitan Phd Khosla
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2020-08-11 | director |
Chaitan Phd Khosla Latest Holdings Summary
Chaitan Phd Khosla currently owns a total of 1 stock. Chaitan Phd Khosla owns 0 shares of Protagonist Therapeutics Inc (PTGX) as of August 11, 2020, with a value of $0.
Latest Holdings of Chaitan Phd Khosla
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2020-08-11 | 0 | 42.57 | 0 |
Holding Weightings of Chaitan Phd Khosla
Chaitan Phd Khosla Form 4 Trading Tracker
According to the SEC Form 4 filings, Chaitan Phd Khosla has made a total of 1 transactions in Protagonist Therapeutics Inc (PTGX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Protagonist Therapeutics Inc is the sale of 2,499 shares on August 11, 2020, which brought Chaitan Phd Khosla around $42,958.
Insider Trading History of Chaitan Phd Khosla
- 1
Chaitan Phd Khosla Trading Performance
Chaitan Phd Khosla Ownership Network
Ownership Network List of Chaitan Phd Khosla
Ownership Network Relation of Chaitan Phd Khosla
Chaitan Phd Khosla Owned Company Details
What does Protagonist Therapeutics Inc do?
Who are the key executives at Protagonist Therapeutics Inc?
Chaitan Phd Khosla is the director of Protagonist Therapeutics Inc. Other key executives at Protagonist Therapeutics Inc include Chief Financial Officer Asif Ali , director & President and CEO Patel Dinesh V Ph D , and Chief Development Officer Suneel Gupta .
Protagonist Therapeutics Inc (PTGX) Insider Trades Summary
Over the past 18 months, Chaitan Phd Khosla made no insider transaction in Protagonist Therapeutics Inc (PTGX). Other recent insider transactions involving Protagonist Therapeutics Inc (PTGX) include a net sale of 165,000 shares made by Patel Dinesh V Ph D , a net sale of 36,975 shares made by William D. Waddill , and a net sale of 39,624 shares made by Asif Ali .
In summary, during the past 3 months, insiders sold 22,203 shares of Protagonist Therapeutics Inc (PTGX) in total and bought 0 shares, with a net sale of 22,203 shares. During the past 18 months, 248,447 shares of Protagonist Therapeutics Inc (PTGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 248,447 shares.
Protagonist Therapeutics Inc (PTGX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protagonist Therapeutics Inc Insider Transactions
Chaitan Phd Khosla Mailing Address
Above is the net worth, insider trading, and ownership report for Chaitan Phd Khosla. You might contact Chaitan Phd Khosla via mailing address: 3832 Bay Center Place, Hayward Ca 94545.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
